Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13.1M
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
12.2M
-
Shares change
-
-53.2K
-
Total reported value, excl. options
-
$508M
-
Value change
-
-$2.9M
-
Number of buys
-
73
-
Number of sells
-
-72
-
Price
-
$41.74
Significant Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q1 2021
168 filings reported holding EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock as of Q1 2021.
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.2M shares
of 13.1M outstanding shares and own 93.17% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.98M shares), JANUS HENDERSON GROUP PLC (1.59M shares), STATE STREET CORP (803K shares), VANGUARD GROUP INC (773K shares), BRANDES INVESTMENT PARTNERS, LP (490K shares), Park West Asset Management LLC (449K shares), DIMENSIONAL FUND ADVISORS LP (328K shares), Invesco Ltd. (322K shares), Smith, Graham & Co., Investment Advisors, LP (313K shares), and ACADIAN ASSET MANAGEMENT LLC (213K shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.